FDA Inspection 1325474 — Florence Lerebours, M.D.
The FDA completed an inspection of Florence Lerebours, M.D. on Jun 18, 2026 in Saint-Cloud. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 18, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint-Cloud (France)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 22727 | 21 CFR 312.64(b) | Safety Reports - Serious Events |
| 7560 | 21 CFR 312.60 | FD-1572, protocol compliance |